Schedule 13G ownership disclosure

DiaMedica Therapeutics Inc

Security class unavailable · CUSIP: 25253X207

Event date: 2018-12-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
598,698
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-19-001495
Form type
SC 13G
Filer
CentreStone Ventures Limited Partnership
CIK
CIK 1765980
Filed
Jan 29, 2019
Reporting period
Dec 06, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub